Conversely, in TRAIL-deficient mice or when TRAIL was blocked by injecting a soluble receptor, the mice developed characteristics of T1D with increased autoimmune inflammation of pancreatic islets [11]. The gene discussed is TNFSF10; the disease is type 1 diabetes mellitus.